Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015


Financial Report: Quintiles

By Kristin Brooks

Published February 13, 2014
4Q Revenues: $1.4 billion (+8%)
4Q Earnings: $72.9 million (+109%)
FY Revenues: $5.1 billion (+5%)
FY Earnings: $226.0 (+28%)
Comments: New business wins were $1.3 billion and $4.9 billion for the quarter and year ended December 31, 2013, respectively, representing a book-to-bill ratio of 1.29 for both the quarter and year, and contributed to an ending backlog of $9.9 billion. Product Development revenues were $775 million in the quarter, up 10%, and $2.9 billion for the year, up 7%. Integrated Healthcare Services revenue was $228.9 million in the quarter, down 6%, and $888.6 million for the year, down 8%.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On